Addus HomeCare Corporation (ADUS) Stock Forecast
Data as of May 2, 2026Healthcare · Current price $99.13 (+2.31%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Feb 25, 2026 | Ben Hendrix | RBC Capital | $139.00 | +40.2% |
| Jan 7, 2026 | Clarke Murphy | Truist Financial | $135.00 | +36.2% |
| Nov 4, 2025 | Andrew Mok | Barclays | $117.00 | +18.0% |
| Dec 16, 2024 | Constantine Davides | JMP Securities | $150.00 | +51.3% |
| Nov 6, 2024 | Scott Fidel | Stephens | $145.00 | +46.3% |
| Oct 10, 2024 | Matthew Gillmor | KeyBanc | $150.00 | +51.3% |
| Sep 23, 2024 | Michael Wiederhorn | Oppenheimer | $145.00 | +46.3% |
| Aug 8, 2024 | Frank Morgan | RBC Capital | $141.00 | +42.2% |
| Aug 7, 2024 | Michael Wiederhorn | Oppenheimer | $140.00 | +41.2% |
| Jun 7, 2024 | Michael Wiederhorn | Oppenheimer | $130.00 | +31.1% |
| May 31, 2024 | Scott Fidel | Stephens | $128.00 | +29.1% |
| May 28, 2024 | Frank Morgan | RBC Capital | $129.00 | +30.1% |
| Apr 23, 2024 | Andrew Mok | Barclays | $83.00 | -16.3% |
| Apr 1, 2024 | Scott Fidel | Stephens | $115.00 | +16.0% |
| Jun 29, 2022 | Scott Fidel | Stephens | $101.00 | +1.9% |
Top Analysts Covering ADUS
ADUS vs Sector & Market
| Metric | ADUS | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 3.00 | 2.24 | 2.41 |
| Analyst Count | 6 | 8 | 18 |
| Target Upside | +29.8% | +1150.2% | +14.9% |
| P/E Ratio | 19.03 | 6.85 | 31.19 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $1.50B | $1.52B | $1.53B | 10 |
| 2027-03-31 | $380M | $385M | $388M | 4 |
| 2027-06-30 | $389M | $394M | $398M | 6 |
| 2027-09-30 | $398M | $403M | $407M | 4 |
| 2027-12-31 | $403M | $408M | $412M | 7 |
| 2028-03-31 | $401M | $406M | $410M | 3 |
| 2028-06-30 | $416M | $421M | $426M | 5 |
| 2028-09-30 | $423M | $428M | $432M | 3 |
| 2028-12-31 | $433M | $438M | $442M | 6 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $6.79 | $6.89 | $6.94 | 9 |
| 2027-03-31 | $1.67 | $1.70 | $1.72 | 3 |
| 2027-06-30 | $1.79 | $1.82 | $1.84 | 3 |
| 2027-09-30 | $1.85 | $1.88 | $1.90 | 4 |
| 2027-12-31 | $2.02 | $2.06 | $2.08 | 3 |
| 2028-03-31 | $1.94 | $1.98 | $2.00 | 4 |
| 2028-06-30 | $2.02 | $2.05 | $2.07 | 4 |
| 2028-09-30 | $2.06 | $2.09 | $2.12 | 6 |
| 2028-12-31 | $2.14 | $2.18 | $2.21 | 4 |
Frequently Asked Questions
What is the analyst consensus for ADUS?
The consensus among 6 analysts covering Addus HomeCare Corporation (ADUS) is Hold with an average price target of $128.67.
What is the highest price target for ADUS?
The highest price target for ADUS is $150.00, set by Constantine Davides at JMP Securities on 2024-12-16.
What is the lowest price target for ADUS?
The lowest price target for ADUS is $83.00, set by Andrew Mok at Barclays on 2024-04-23.
How many analysts cover ADUS?
6 analysts have issued ratings for Addus HomeCare Corporation in the past 12 months.
Is ADUS a buy or sell right now?
Based on 6 analyst ratings, ADUS has a consensus rating of Hold (3.00/5) with a +29.8% upside to the consensus target of $128.67.
What are the earnings estimates for ADUS?
Analysts estimate ADUS will report EPS of $6.89 for the period ending 2026-12-31, with revenue estimated at $1.52B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.